Mexico Registro Sanitario Basics for Medical Devices

1. Key takeaways

The Registro Sanitario is the prior health authorization that Mexico imposes on the manufacture, sale and distribution of medical devices. It is issued by the Ministry of Health through COFEPRIS, and no device may legally be manufactured, marketed or distributed in Mexico without it. The legal foundation is Article 82 of the Reglamento de Insumos para la Salud (RIS). The first validity term is 5 years under Article 376 of the Ley General de Salud (LGS), and subsequent renewals can reach 10 years. Two structural points deserve attention from the outset. First, the certificate attaches to a product and is held by a Mexican legal entity, not by the foreign manufacturer. Second, registration and import authorization are separate formalities, so a certificate alone does not unlock importation. The validity architecture was adjusted by amendments published in 2026, which is why teams planning multi-year budgets for the Mexican market need to model the first term and the renewal terms as distinct stages rather than as a single continuous entitlement.

2. Legal basis

The requirements that govern the registro sanitario are spread across the general health law, its implementing regulation, a 2025 agreement on low-risk products, and the labeling standard checked at the time of application. The table below consolidates the instruments, the specific provisions, and the practical point that each one establishes, so that the obligations can be traced back to a citable source before any dossier is assembled.

3. Expert insights

Insight 1: the registro sanitario is a product permit, not a company license. Article 82 of the RIS deliberately separates the registration of the product from the authorization of the establishment. The product must be registered, while any site engaged in processing must separately file the operating notice, the aviso de funcionamiento. The two tracks run in parallel, and neither substitutes for the other. A company that holds a registered establishment but no product registration still cannot place the device on the market, and a registered product manufactured or processed at an establishment without its operating notice is equally incomplete. Scheduling them as a single merged task is a recurring planning error.

Insight 2: the certificate records the holder, not the manufacturer. A foreign manufacturer cannot appear as the holder named on the registration. This single rule shapes the entire licensing structure: it determines which entity signs the application, which entity communicates with COFEPRIS, which entity appears on labels, and how difficult any later transfer of the certificate will be. Choosing the holder is therefore not an administrative detail to be settled at filing time but a strategic decision to be made before the dossier is even drafted.

Insight 3: the validity structure changed in 2026. Article 376 of the LGS, as adjusted by the amendment decree published in DOF 2026-01-15, keeps the first registration term at 5 years, while subsequent renewals can reach 10 years. However, Article 190 Bis 3 of the RIS amendment decree (DOF 2026-04-24) currently limits the 10-year first renewal term to devices that are manufactured in Mexico; devices manufactured abroad are not covered by that extended treatment. Importers therefore should not assume the longer renewal horizon applies to their certificates until the scope of that provision changes.

Insight 4: the consequence of not holding the registration is a prohibition, not merely a fine. The wording of Article 82 uses the verb meaning that these products require the authorization. Without it, the legal precondition for manufacture, sale and distribution simply does not exist. This is a categorically different situation from an ordinary notification duty, where non-compliance triggers a sanction but the underlying activity remains possible. Here the activity itself is unlawful, which changes how risk should be assessed.

Insight 5: registration and import authorization are independent of each other. Holding a registro sanitario does not by itself allow importation; each import operation still requires the corresponding import authorization. Conversely, products listed in Annex II of the agreement are exempt from registration and also exempt from the import authorization, yet they remain subject to GMP obligations and to technovigilance duties. Exemption from one layer never means exemption from every layer.

4. Practical recommendations

• At project launch, split the product registration and the facility operating notice into two parallel workstreams with their own schedules, so that neither one stalls the other.
• Maintain a ledger of the holder name, address and product information recorded on the certificate, and route every change through the amendment procedure rather than leaving discrepancies in place.
• Build long-term budgets around the structure of a first term of 5 years followed by renewals of up to 10 years, and for imported devices note that the RIS amendment decree does not yet extend the longer renewal treatment to foreign-manufactured products.
• For products exempt from registration under Annex II, still keep GMP and technovigilance evidence on file; exemption from registration is not a reason to dismantle the quality system documentation.

5. Verification checklist

• □ Confirmed whether the product requires the registro sanitario or falls under Annex II / Annex III
• □ The facility operating notice has been scheduled separately from the product registration
• □ The holder of the certificate is a Mexican legal entity
• □ The validity term is recorded as a first term of 5 years, and the renewal structure has been re-checked against Article 376 of the LGS
• □ Import authorization has been scheduled separately from the registration

Regulatory information verified as of October 28, 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Mexican market. Our team manages COFEPRIS registrations and equivalence (equivalencia) reviews, coordinates third-party authorised centre routes, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com